These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 31845129)
21. Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer. Liubomirski Y; Lerrer S; Meshel T; Morein D; Rubinstein-Achiasaf L; Sprinzak D; Wiemann S; Körner C; Ehrlich M; Ben-Baruch A Front Immunol; 2019; 10():804. PubMed ID: 31105691 [TBL] [Abstract][Full Text] [Related]
22. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A. Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639 [TBL] [Abstract][Full Text] [Related]
23. Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathway. Li T; Zhang Q; Zhang J; Yang G; Shao Z; Luo J; Fan M; Ni C; Wu Z; Hu X BMC Cancer; 2014 Feb; 14():96. PubMed ID: 24529079 [TBL] [Abstract][Full Text] [Related]
24. Downregulation of Smurf2, a tumor-suppressive ubiquitin ligase, in triple-negative breast cancers: involvement of the RB-microRNA axis. Liu X; Gu X; Sun L; Flowers AB; Rademaker AW; Zhou Y; Kiyokawa H BMC Cancer; 2014 Feb; 14():57. PubMed ID: 24485087 [TBL] [Abstract][Full Text] [Related]
25. miR-613 inhibits cell migration and invasion by downregulating Daam1 in triple-negative breast cancer. Xiong H; Yan T; Zhang W; Shi F; Jiang X; Wang X; Li S; Chen Y; Chen C; Zhu Y Cell Signal; 2018 Apr; 44():33-42. PubMed ID: 29339084 [TBL] [Abstract][Full Text] [Related]
26. Long non-coding RNA PCAT29 regulates the growth, migration and invasion of human triple-negative breast cancer cells. Lu C; Li HL; Zhang X; Zhao J; Zheng WH J BUON; 2020; 25(2):621-626. PubMed ID: 32521844 [TBL] [Abstract][Full Text] [Related]
27. Desmoglein 2 and desmocollin 2 depletions promote malignancy through distinct mechanisms in triple-negative and luminal breast cancer. Han JY; Che N; Mo J; Zhang DF; Liang XH; Dong XY; Zhao XL; Sun BC BMC Cancer; 2024 Apr; 24(1):532. PubMed ID: 38671389 [TBL] [Abstract][Full Text] [Related]
28. Schlafen12 Reduces the Aggressiveness of Triple Negative Breast Cancer through Post-Transcriptional Regulation of ZEB1 That Drives Stem Cell Differentiation. Al-Marsoummi S; Vomhof-DeKrey E; Basson MD Cell Physiol Biochem; 2019; 53(6):999-1014. PubMed ID: 31838790 [TBL] [Abstract][Full Text] [Related]
29. Down-regulating GRP78 reverses pirarubicin resistance of triple negative breast cancer by miR-495-3p mimics and involves the p-AKT/mTOR pathway. Liu M; Yang J; Lv W; Wang S; Du T; Zhang K; Wu Y; Feng X Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34935899 [TBL] [Abstract][Full Text] [Related]
30. Platinum complexes inhibit HER-2 enriched and triple-negative breast cancer cells metabolism to suppress growth, stemness and migration by targeting PKM/LDHA and CCND1/BCL2/ATG3 signaling pathways. Bai X; Ali A; Lv Z; Wang N; Zhao X; Hao H; Zhang Y; Rahman FU Eur J Med Chem; 2021 Nov; 224():113689. PubMed ID: 34293698 [TBL] [Abstract][Full Text] [Related]
31. Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer. Kabil N; Bayraktar R; Kahraman N; Mokhlis HA; Calin GA; Lopez-Berestein G; Ozpolat B Breast Cancer Res Treat; 2018 Oct; 171(3):593-605. PubMed ID: 29971628 [TBL] [Abstract][Full Text] [Related]
32. miR-365 inhibits cell invasion and migration of triple negative breast cancer through ADAM10. Liu F; Zhuang L; Wu R; Li D J BUON; 2019; 24(5):1905-1912. PubMed ID: 31786854 [TBL] [Abstract][Full Text] [Related]
33. MiR-107 down-regulates SIAH1 expression in human breast cancer cells and silencing of miR-107 inhibits tumor growth in a nude mouse model of triple-negative breast cancer. Zhang L; Ma P; Sun LM; Han YC; Li BL; Mi XY; Wang EH; Song M Mol Carcinog; 2016 May; 55(5):768-77. PubMed ID: 25851994 [TBL] [Abstract][Full Text] [Related]
34. RNF144A functions as a tumor suppressor in breast cancer through ubiquitin ligase activity-dependent regulation of stability and oncogenic functions of HSPA2. Yang YL; Zhang Y; Li DD; Zhang FL; Liu HY; Liao XH; Xie HY; Lu Q; Zhang L; Hong Q; Dong WJ; Li DQ; Shao ZM Cell Death Differ; 2020 Mar; 27(3):1105-1118. PubMed ID: 31406303 [TBL] [Abstract][Full Text] [Related]
35. Suppression of Spry1 inhibits triple-negative breast cancer malignancy by decreasing EGF/EGFR mediated mesenchymal phenotype. He Q; Jing H; Liaw L; Gower L; Vary C; Hua S; Yang X Sci Rep; 2016 Mar; 6():23216. PubMed ID: 26976794 [TBL] [Abstract][Full Text] [Related]
36. USP2 promotes cell migration and invasion in triple negative breast cancer cell lines. Qu Q; Mao Y; Xiao G; Fei X; Wang J; Zhang Y; Liu J; Cheng G; Chen X; Wang J; Shen K Tumour Biol; 2015 Jul; 36(7):5415-23. PubMed ID: 25687182 [TBL] [Abstract][Full Text] [Related]
37. KR-33028, a potent inhibitor of the Na Amith SR; Wilkinson JM; Fliegel L Biochem Pharmacol; 2016 Oct; 118():31-39. PubMed ID: 27521504 [TBL] [Abstract][Full Text] [Related]
38. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1. Chen LL; Zhang ZJ; Yi ZB; Li JJ Br J Cancer; 2017 Jun; 117(1):78-88. PubMed ID: 28571042 [TBL] [Abstract][Full Text] [Related]
39. Ubiquitin ligase CHIP functions as an oncogene and activates the AKT signaling pathway in prostate cancer. Cheng L; Zang J; Dai HJ; Li F; Guo F Int J Oncol; 2018 Jul; 53(1):203-214. PubMed ID: 29693147 [TBL] [Abstract][Full Text] [Related]
40. RSK-mediated down-regulation of PDCD4 is required for proliferation, survival, and migration in a model of triple-negative breast cancer. Cuesta R; Holz MK Oncotarget; 2016 May; 7(19):27567-83. PubMed ID: 27028868 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]